Before President Barack Obama announced a precision medicine initiative in his State of the Union address last week, many Americans were probably unfamiliar with the term. Not cancer researchers.
“Oncology has been on the leading edge of precision medicine,” said Dr. Gary Gilliland, president and director of Fred Hutchinson Cancer Research Center and an expert in cancer genetics. Much of his career has centered on precision medicine, which focuses on targeted treatments for patients.
Gilliland and other top cancer researchers praised the initiative Friday when the Obama administration released additional details, including plans to amass genetic and health data on more than a million American volunteers to better understand genetic causes of disease and streamline drug discovery.